Positive-sense single-stranded RNA virus

Characteristics and genome organization

• Genome: a single linear strand of RNA that often contains a 5' cap or internal ribosome entry sites to initiate translation.
• Translation strategy: some viruses produce a single polyprotein that is proteolytically cleaved; others use subgenomic RNAs or leaky scanning to express multiple proteins.
• Replication: RNA-dependent RNA polymerases encoded by the virus synthesize a negative-sense antigenome that serves as a template for new positive genomes.
• Structure: capsid symmetry and presence or absence of an envelope vary widely across families, influencing stability and transmission.
• Host range: includes animals, plants, fungi, and protists; tropism is determined by receptor use and intracellular compatibility.

Historically, recognition of positive-sense RNA genomes helped clarify how viruses hijack host translation. Early molecular studies showed that purified genomic RNA from some viruses is infectious by itself because it can serve as mRNA. Advances in sequencing and structural biology have revealed diverse genome sizes and arrangements among (+)ssRNA families and clarified relationships between replication complexes and host membranes.

Examples and significance

Many medically and agriculturally important viruses are (+)ssRNA types. Representative human and animal pathogens include hepacivirus C (hepatitis C virus), West Nile virus, dengue virus, severe acute respiratory syndrome viruses such as SARS and MERS, broader groups like the coronaviruses, and recently prominent examples such as SARS-CoV-2. Less severe but widespread agents include rhinoviruses, common causes of the common cold. These examples illustrate the clinical range of (+)ssRNA viruses from mild to life-threatening.

Distinguishing features and practical implications include how quickly translation begins after entry, the strategies viruses use to express multiple proteins from a single RNA, and how replication complexes form on intracellular membranes. Understanding these features informs antiviral design and vaccine strategies: targeting the viral RNA polymerase, proteases that cleave polyproteins, or unique entry mechanisms are common approaches. For more technical summaries and family-level classifications, consult specialized resources and reviews (overview, molecular details).